Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately
The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.
Cardiologist sues hospital after he was allegedly let go for sharing safety concerns
The veteran interventional cardiologist claims he was pushed out after repeatedly asking for more coverage from cardiothoracic surgeons in addition to other improvements. The hospital, meanwhile, described the lawsuit as a “collection of false allegations."
Why all heart patients should be vaccinated against the flu, COVID-19, RSV
The American College of Cardiology has shared new recommendations highlighting the protective benefits of a variety of vaccines. The new guidance also examines how to speak with patients who are hesitant to be vaccinated.
Heart surgeons see more potential in AI than colleagues from other fields
Cardiac surgeons see significant value in AI's ability to assist clinicians with administrative tasks and patient selection. When it comes to making clinical decisions, however, there is still a certain amount of skepticism.
New Apple Watch Ultra 3 makes early hypertension detection a priority
"This tool empowers patients and clinicians to work together, putting prevention at the center of care," said Ami B. Bhatt, MD, ACC chief innovation officer. "What we really want to do is create patient agency and reach as many people as we can for earlier detection of high blood pressure."

Carotid endarterectomy (CEA) is not associated with a significant reduction in the risk of dementia, according to a new analysis published in the European Journal of Vascular & Endovascular Surgery.[1] However, the study’s authors noted, it did still lead to considerable improvements in stroke risk.

Carotid endarterectomy does not reduce long-term dementia risk

However, researchers noted, there was still a clear improvement in stroke risk.

Regulatory roundup: FDA clears new solutions from Boston Scientific, CathVision, Franklin Mountain Medical

It has been a busy few weeks for the FDA, with plenty of big-name approvals and recalls making the news, but there have also been some other big announcements related to solutions receiving FDA clearance.

Real-world Watchman patients experiencing fewer complications after LAAO than seen in clinical trials

The study's authors compared findings from the PROTECT-AF and PREVAIL clinical trials with data from the NCDR LAAO Registry, focusing on short-term and long-term outcomes.

interventional cardiology heart failure cleveland clinic

4 promising heart failure therapies interventional cardiologists should keep an eye on

The devices, currently being investigated by teams of heart specialists, could make a big impact in the years ahead.

Brugada arrhythmogenic substrate that causes VT and sudden cardiac death. This study showed ablation of this substrate area could help prevent sudden cardiac arrest in these patients.

Epicardial ablation in Brugada syndrome reduces sudden cardiac death

A late-breaking study at Heart Rhythm 2022 found epicardial ablation in Brugada syndrome helped significantly reduce sudden cardiac arrest in these patients, increasing their survival.

Veteran cardiologist Morton M. Mower, co-inventor of the automatic ICD, dies at 89

“I think he was the most brilliant person I’ve ever met," one long-time colleague said.

Same-day discharge for AFib ablation a success thanks to telehealth

The new analysis, presented during Heart Rhythm 2022, focused on patients treated at a high-volume facility during the COVID-19 pandemic.

FDA approves mavacamten for obstructive hypertrophic cardiomyopathy

The FDA’s approval was based on data from the EXPLORER-HCM trial, which showed that mavacamten was superior to a placebo for treating obstructive HCM and associated with no significant long-term, treatment-related adverse events.

Clinical

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

Cardiologist sues hospital after he was allegedly let go for sharing safety concerns

Why all heart patients should be vaccinated against the flu, COVID-19, RSV

Heart surgeons see more potential in AI than colleagues from other fields

New Apple Watch Ultra 3 makes early hypertension detection a priority